🧬 Aging Wiki

Effect of lanosterol on human cataract nucleus

4 min read

Shanmugam et al. 2015 — Lanosterol did not clear human cataract nuclei ex vivo

TL;DR

Forty surgically removed nuclei from human age-related cataracts were allocated 20 per arm to nominal 25 mM lanosterol or matched vehicle for six days. The authors described allocation as random but gave no sequence-generation or concealment method. Two masked observers found no agreed opacity regression in either arm; mean day-6 grades also did not differ significantly (2.80 lanosterol versus 2.65 control; P=0.356).1 This is direct human-tissue evidence, but it tests excised cataract nuclei under a single ex-vivo exposure rather than drug delivery to an intact, earlier-stage lens. gap/contradictory-evidence

Design

  • Specimens: 40 age-related cataractous nuclei removed during manual small-incision cataract surgery; diabetic and post-traumatic cataracts were excluded. The paper did not state explicitly whether all nuclei came from different patients.
  • Allocation: The authors reported “random selection” of 20 nuclei into the lanosterol arm and 20 into control, but did not report sequence generation, allocation concealment, stratification by baseline opacity, or a power calculation.
  • Intervention: Immersion at room temperature in the dark for six days. The reported 1.1 L active mixture contained 12.5 g lanosterol, 1.1 g disodium EDTA, 0.55 g alkyl dimethyl benzyl ammonium chloride, 200 mL ethanol, and double-distilled water to volume; the control was prepared similarly without lanosterol. Lanosterol was only partly soluble, so 25 mM was a nominal formulation concentration rather than a measured dissolved exposure.
  • Assessment: Standardized pre/post photographs were randomly presented to two masked observers for ordinal grading from 0 (clear gridlines) to 3 (gridlines completely obscured). The paper did not specify whether masking covered treatment arm, time point, or both, and did not describe adjudication of discordant grades or how discordant ratings entered the mean-grade analysis.
  • Endpoint: Change in visible nucleus opacity; no in-vivo visual-acuity or drug-delivery endpoint.

Key result

The two observers agreed on progression in 18/20 lanosterol nuclei and 14/20 controls. They agreed on no change in 0/20 and 4/20, respectively, and on regression in none. Two nuclei in each arm had discordant observer classifications; one lanosterol nucleus was called regression by one observer only.1

Mean opacity grade was 1.45 ± 0.510 before and 2.80 ± 0.410 after immersion in the lanosterol arm, versus 1.55 ± 0.605 and 2.65 ± 0.587 in controls. Separate two-sample t-tests found no between-arm difference either before treatment (P=0.576; mean-difference 95% CI, −0.259 to 0.459) or at day 6 (P=0.356; 95% CI, −0.476 to 0.176). The paper did not report a treatment-by-time analysis or a count-based test of progression, and a nonsignificant result is not an equivalence demonstration.1

Interpretation and limitations

This result shows no reversal under the tested nominal concentration, vehicle, duration, temperature, and excised-nucleus preparation. It does not prove that every lanosterol derivative, delivery system, cataract subtype, or disease stage must fail. The specimens lacked capsule and cortex, represented surgically treated disease, and were immersed ex vivo rather than exposed through a clinically usable formulation. The ordinal endpoint, incomplete reporting of randomization and masking, unmeasured dissolved exposure, small sample, and absence of a longitudinal treatment-effect model further limit inference.

A linked post-publication comment noted that removing the capsule and epithelium can itself promote opacification and that one fixed exposure duration did not account for nuclear density. The authors agreed that these factors could affect the result, while arguing that bare nuclei should also give lanosterol more direct access to lens fibers; neither exchange altered the reported null between-arm comparison.2

Cited by wiki pages

[Auto-populated by Obsidian backlinks]

Footnotes

  1. Shanmugam PM, Barigali A, Kadaskar J, Borgohain S, Mishra DKC, Ramanjulu R, Minija CK · doi:10.4103/0301-4738.176040 · PMID:26862091 · PMCID:PMC4784074 · 40 surgically removed human age-related cataract nuclei, 20 per arm · six-day ex-vivo immersion · Indian Journal of Ophthalmology 2015;63(12):888–890. ↩ ↩2 ↩3

  2. Venkatesh R, Gurav P, Tibrewal S · methodological comment · doi:10.4103/0301-4738.187689 · PMID:27488164 · PMCID:PMC4991188; and Shanmugam PM et al. · authors’ reply · doi:10.4103/0301-4738.187691 · PMID:27488165 · PMCID:PMC4991189 · Indian Journal of Ophthalmology 2016;64:475–476. ↩

Graph View

Backlinks